“Intraperitoneal pretreatments with … quaternary opiate antagonist MN (which does not cross the blood-brain barrier effectively) … conditioned place aversions produced by low IP doses of morphine (0.05 mg/kg), but not the place aversions produced by lithium … IP), or by high doses of naloxone (10 mg/kg SC).”